Meticulous Research®—a leading market research company, published a research report titled, ‘Bone Growth Stimulators Market by Product (Stimulation Device [External, Ultrasonic, Implantable], Bone Morphogenetic Proteins, Platelet Rich Plasma), Application (Spinal Fusion, Fracture, Oral Surgeries), End User (Hospital, ASC) - Global Forecast to 2030.’
Download Free Sample Report Now- https://www.meticulousresearch.com/download-sample-report/cp_id=3530
According to this latest publication from Meticulous Research®, the bone growth stimulators market is projected to reach $1.94 billion by 2030, at a CAGR of 4.9% from 2023 to 2030. The growth of this market is driven by the increasing preference for minimally invasive treatments, rising cases of bone fractures and spinal injuries, increasing geriatric population and subsequent increase in the cases of orthopedic diseases and injuries, and growing incidences of sports injuries. In addition, the growing number of hospitals and surgical centers worldwide, increasing utilization of platelet-rich plasma (PRP) in other applications, and emerging economies offer opportunities for the growth of this market.
The bone growth stimulators market is segmented by Product (Bone Growth Stimulation Devices [External Bone Growth Stimulators {Capacitive Coupling Devices, Combined Magnetic Field Devices, and Pulsed Electromagnetic Field Devices}, Ultrasonic Bone Growth Stimulators, Implantable Bone Growth Stimulators], Bone Morphogenetic Proteins, and Platelet-Rich Plasma), Application (Spinal Fusion Surgeries, Union & Non-union Bone Fractures, Oral and Maxillofacial Surgeries, and Other Applications), End User (Hospitals & Specialized clinics, Ambulatory Surgery Center, and Other End-User), and Geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).
Based on product, in 2023, the bone growth stimulation devices segment is expected to account for the largest share of the bone growth stimulators market. Bone growth stimulation devices that promote bone healing in bone fractures. The large market share of this segment is attributed to the increasing cases of bone fractures, high demand for cost-effective & less painful treatments, and high preference for non-invasive or minimally invasive surgical treatments.
Based on application, the delayed union & non-union bone fractures segment is projected to register the highest CAGR over the forecast period. The growth of this segment is attributed to the rising cases of bone fractures among the geriatric population with orthopedic problems. Furthermore, the delayed union and non-union bone fractures are due to a lack of nutrition and blood supply. According to the International Osteoporosis Foundation, osteoporosis causes about 4.3 million fragility fractures and healthcare spending of nearly $59.012 million (€56 billion) annually in Europe. In addition, the number of women and men aged 75 years and over is expected to rise between 2019 and 2034, nearly 29% and 42%, respectively, resulting in a significant increase in osteoporotic fractures.
Speak to our Analysts: https://www.meticulousresearch.com/speak-to-analyst/cp_id=3530
Based on end user, in 2023, the hospitals and specialized clinics segment is expected to account for the largest share of the bone growth stimulators market. The large market share of this segment is attributed to the wide availability of hospitals in both urban & rural areas worldwide, the increasing number of individuals with various conditions visiting hospitals, and the rising number of doctors and surgeons.
Based on geography, in 2023, North America is expected to account for the largest share of the bone growth stimulators market. North America’s major market share is attributed to the high spending on healthcare, the rising geriatric population, technological advancements, and the high adoption rate of innovative products in the healthcare sector in the region.
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/bone-growth-stimulator-market-3530
Key Players:
Key companies operating in the bone growth stimulators market are Orthofix Medical Inc.(U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Medtronic, plc (Ireland), Stryker Corporation (U.S.), Johnson & Johnson Private Limited (U.S.), DJO, LLC (U.S.), Bioventus LLC (U.S.), OssaTechnics BV (Germany), Arthrex GmbH (U.S.), Smith & Nephew plc (U.K.), and ITO CO., Ltd. (Japan).
Key questions answered in the report-
- Which are the high-growth market segments in terms of product, application, end user, and geography?
- What was the historical market for bone growth stimulators across the globe?
- What are the market forecasts and estimates for the period 2023–2030?
- What are the major drivers, restraints, opportunities, and challenges in the bone growth stimulators market?
- Who are the major players in the bone growth stimulators market?
- How is the competitive landscape, and who are the market leaders in the bone growth stimulators market?
- What are the recent developments in the bone growth stimulators market?
- What are the different strategies adopted by the major players in the bone growth stimulators market?
- What are the geographic trends and high-growth regions/countries?
Quick Buy – https://www.meticulousresearch.com/Checkout/30065033
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Osteoporosis and osteoarthritis are among the common disabling joint disorders that are affecting millions of elderly people across the world.
The cause of delayed bone healing and fractures is not known, however, it is creating a large economic impact on the market of bone growth stimulators.Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-828Various alternative therapies and treatments for fractures, which include synthetic bone grafts, amputation, and allografts, as well as non-invasive therapies, such as electrical bone growth stimulation and low-intensity ultrasound stimulations, have been introduced, which are responsible for driving the global bone growth stimulators market.
According to the World Bank, around 1.25 million people get injured in road accidents, which leads to fractures and the requirement of fusion surgeries for their treatment every year.
These are some of the prime factors that are expected to drive the global Bone growth stimulators market over the forecast period 2019-2029.Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-828The North America bone growth stimulators market and Europe bone growth stimulators market combined are expected to hold a share of approximately 65% of the global bone growth stimulators market during the forecast period.
Non-invasive bone growth stimulators are also segmented into various other sub-segments such as Capacitive Coupling (CC) devices, Pulsed Electromagnetic Field (PEMF) devices, Combined Magnetic Field (CMF) devices, and ultrasound bone growth stimulators.
Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-828Based on applications, the bone growth stimulators market has been segmented into trauma injury & fractures, spinal fusion surgeries, and osteogenesis.
The External Bone Growth Stimulators Market report published by Market.us is an extensive anthology of the essential strand of the External Bone Growth Stimulators market, assessed thoroughly by our team of the inquisitor.
The market infiltration report offers perspicacious data and information relevant to the market to familiarize the readers with the lucrative growth anticipation existing in this industry, eventually helping them contrive effective business strategies.
The External Bone Growth Stimulators market report has been well organized curated using industry-verified data to offer guidance concerned with the leading manufacturers and suppliers affianced in this sector.
It further focuses on their pricing analysis, gross revenue, product portfolio, sales network & distribution channels, profit margins, and financial estimation.
Regional assessment of External Bone Growth Stimulators market unlocks a superfluity of unexploited opportunities in regional and domestic market places.
Detailed company profiling accredits users to evaluate company shares analysis, emerging product lines, the scope of new markets, pricing strategies, innovation probability, and much more.The study throws light on the recent trends, technologies, approaches, and tools, which can boost the performance of companies.
